Novartis | NVS - Eps Ganancias Por Acción

Precio De Mercado
145.47
Cambio Diario
-2.06 -1.40%
Mensual
-3.46%
Anual
29.62%
Q2 Expectativa
142.62

Fiscal Calendario Real Consenso Anterior Fecha
FY2025Q1 Mar/2026 2.11 1.90 Apr/28




Eps Cambio Fecha
AbbVie USD 2.71 0.85 2025-12
Amgen USD 5.29 0.35 2025-12
AstraZeneca USD 2.12 0.26 2025-12
Bausch Health Companies USD 1.08 0.08 2025-12
Biogen USD 1.99 2.82 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Canopy Growth CAD -0.05 0.03 2025-12
Corcept Therapeutics USD 0.2 0.04 2025-12
Drreddys Laboratories INR 0.16 0.04 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Glaxosmithkline GBP 0.21 0.51 2025-12
J&J USD 2.7 0.24 2026-03
Merck USD 2.04 0.54 2025-12
Novartis USD 1.54 0.5 2025-12
Novartis USD 1.54 0.48 2025-12
Pacira USD 0.06 0.64 2025-12
Perrigo USD 0.77 0.03 2025-12
Pfizer USD 0.66 0.21 2025-12
Phibro Animal Health USD 0.78 0.1 2025-12
Prestige Brands USD 1.14 0.07 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sanofi EUR 1.88 0.35 2026-03
Sanofi EUR 2.17 2.84 2026-03
Supernus Pharmaceuticals USD -0.07 0.73 2025-12
Zoetis USD 1.48 0.22 2025-12